Previous studies suggested that the prevalence of EGFR mutations in East Asian population was approximately 50% (13–15), in which EGFR L858R and EGFR 19del were the two most frequent mutations with roughly equal prevalence of around 20% in lung adenocarcinoma patients (13–15). The gene discussed is EGFR; the disease is lung adenocarcinoma.